← All Fortress Biotech, INC filings

Fortress Biotech, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
FBIO
Fortress Biotech, INC
SCHEDULE: Fortress Biotech: Ownership Filing Confirms Holdings
A Schedule 13G filing confirms the beneficial ownership of Fortress Biotech, Inc. common stock by several entities associated with Millennium Management.
NASDAQ
FBIO
Fortress Biotech, INC
SCHEDULE: Highbridge Capital Management Discloses Fortress Biotech Stake
Highbridge Capital Management, LLC has filed a Schedule 13G, reporting beneficial ownership of 7.8% of Fortress Biotech, Inc. common stock, primarily through warrants.